Shopping Cart
- Remove All
- Your shopping cart is currently empty
ORIC-101 is a highly effective and selective glucocorticoid receptor antagonist (EC50: 5.6 nM). It also has anti-cancer activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,420 | 10-14 weeks | |
50 mg | $3,180 | 10-14 weeks | |
100 mg | $4,300 | 10-14 weeks |
Description | ORIC-101 is a highly effective and selective glucocorticoid receptor antagonist (EC50: 5.6 nM). It also has anti-cancer activity. |
Targets&IC50 | GR:(EC50)5.6 nM |
In vitro | ORIC-101 (1-1000 nM) dose-dependently decreases the expression of n GR-mediated target gene (IC50s: 17.2 and 21.2 nM, respectively). ORIC-101 displays markedly reduced androgen receptor agonism (EC50, 2500 nM) and CYP2C8 and CYP2C9 inhibition profiles (IC50, >10 μM)[1]. |
In vivo | In OVCAR5 xenograft tumor in cortisol-treated mice, ORIC-101 (75 mg/kg, P.O. twice a day for 16-22 days) increases the anti-tumor activity in combination with gemcitabine and carboplatin[1]. |
Molecular Weight | 501.74 |
Formula | C34H47NO2 |
Cas No. | 2222344-98-9 |
Relative Density. | 1.11 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.